Routine antenatal screening for hepatitis B using pooled sera: Validation and review of 10 years experience

Journal of Clinical Pathology

Volumn 51, Issue 5, 1998, Pages 392-395

  Cunningham, R ^a   Northwood, J L ^a   Kelly, C D ^a   Boxall, E H ^b   Andrews, N J ^c  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b HPA Birmingham Public Health Laboratory   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Antenatal; Hepatitis B; Screening

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ARTICLE; DIAGNOSTIC ACCURACY; DISEASE CARRIER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SEROPREVALENCE; VERTICAL TRANSMISSION;

EID: 0031864671     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.5.392     Document Type: Article

References (6)

1. Fields BN, Knipe DM, Howley PM. Virology. Philadelphia: Lippincott-Raven, 1996.
2. Chrystie IL, Sumner D, Palmer S, et al. Screening of pregnant women for evidence of current hepatitis B infection: selective or universal? Health Trends 1992;24:13-15.
3. Department of Health. Immunisation against infectious disease. London: HMSO, 1996.
4. Boxall EH. Antenatal screening for carriers of hepatitis B virus. BMJ 1995;311:1178-9.
5. Dwyer MJ, McIntyre PG. Antenatal screening for hepatitis B surface antigen: an appraisal of its value in a low prevalence area. Epidemiol Infect 1996;117:121-31.
6. Boxall EH, Peterson S, Diment J, et al A novel assay for hepatitis B e markers. J Med Virol 1997;52:280-5.